Pay in 4 interest-free payments of $6.44 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
HbA1c reductions of 1.87-2.59% observed SURMOUNT program (Obesity): SURMOUNT-1 showed 20.9% weight loss at 72 weeks
Improved Lipid and Metabolic Markers : Experimental observations with Tesamorelin have reported reductions in triglycerides , total cholesterol, and non-HDL cholesterol, alongside improved adiponectin signaling
Novo Nordisk), have both demonstrated around 20% weight loss after 72 weeks in previous clinical trials (SURMOUNT-1
Its platform integrates tools for nutrition, mental health, and activity tracking to help users achieve sustainable, long-term results
US$ 26.12
US$ 28.70
US$ 28.77
